Innoviva, Inc. — Director's Dealing 2010

Nov 30, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2010-11-29

Reporting Person: GLAXOSMITHKLINE PLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-11-29	Common Stock	P	5750000	$22.5	Acquired	5750000	Indirect

Footnotes

F1: The amount of Common Stock reported as beneficially owned by the Reporting Person following the reported transaction does not include the Reporting Person's previously disclosed beneficial ownership of 9,401,499 shares of Class A Common Stock of Theravance,Inc. (the "Class A Common Stock"), which are held of record by GlaxoSmithKline LLC and Glaxo Group Limited ("GGL"), each of which is a wholly-owned subsidiary of the Reporting Person. Each share of Class A Common Stock may be converted into one share of Common Stock at any time.

F2: Shares of Common Stock are held of record by GGL.